Financials data is unavailable for this security.
View more
Year on year Gain Therapeutics Inc 's revenues fell -60.62% from 140.11k to 55.18k. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a loss of 17.59m to a larger loss of 22.27m.
Gross margin | -- |
---|---|
Net profit margin | -- |
Operating margin | -- |
Return on assets | -115.33% |
---|---|
Return on equity | -188.83% |
Return on investment | -170.44% |
More ▼
Cash flow in USDView more
In 2023, Gain Therapeutics Inc increased its cash reserves by 61.10%, or 4.49m. Cash Flow from Financing totalled 12.64m or 22,909.28% of revenues. In addition the company used 18.87m for operations while cash from investing totalled 10.22m.
Cash flow per share | -1.33 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.4682 |
---|---|
Tangible book value per share | 0.4619 |
More ▼
Balance sheet in USDView more
Current ratio | 2.84 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.0413 |
---|---|
Total debt/total capital | 0.0396 |
More ▼